NCT05553678

The Effect of MDZ on Movement During UIA Clipping

Effects of Midazolam on the Occurrence of Intraoperative Movement in Patients Undergoing Unruptured Intracranial Aneurysm Clipping Surgery: a Prospective Randomized Controlled Trial

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 64 (estimated)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

This study is a randomized, controlled, double-blinded, and parallel design study. A total 64 patients will be randomized to receive midazolam or normal saline during unruptured intracranial aneurysm clipping surgery.

Conditions

• Intraoperative Movement

Interventions

Type	Name	Description
DRUG	Midazolam	Midazolam (0.03 mg/kg/30 min) will administered during UIA clipping through microscope.
DRUG	Normal saline	Normal saline (0.03 mg/ml/30 min) will administered during UIA clipping through microscope.

Timeline

• Start date: 2022-09-29
• Primary completion: 2023-09-30
• Completion: 2023-12-31
• First posted: 2022-09-23
• Last updated: 2022-10-26

Locations

1 site across 1 country: South Korea